Clinical diagnostics in patients with cerebral infarction due to covid-19

The Corona Virus Disease 19 (COVID-19) outbreak is a deadly disease of concern to the world, including Indonesia. Reported cases of death show a high number with more than 3800 deaths reported. This disease can induce Cytokine Storm Syndrome (CSS) and interfere with the Blood-Brain Barrier (BBB), causing coagulopathy and hypoxia, which in turn lead to cerebral edema in the brain. This research uses a case study approach, with a detailed examination of one event. In this case, cerebral infarction was caused by COVID-19 as evidenced by laboratory results in the presence of symptoms of inflammation, CSF, sepsis, and coagulopathy. These symptoms can result in cerebral infarction and hypercoagulability. therapeutic interventions are carried out in reducing inflammation, reducing cerebral edema, and preventing secondary infection. COVID-19 in this case can have a deleterious effect on patients with cerebral infarction. Proper treatment is needed to give better results.